These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 30907673)

  • 1. Advances in prognostic markers for colorectal cancer
    Duan L; Yang W; Wang X; Zhou W; Zhang Y; Liu J; Zhang H; Zhao Q; Hong L; Fan D
    Expert Rev Mol Diagn; 2019 Apr; 19(4):313-324. PubMed ID: 30907673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive and prognostic biomarkers in colorectal cancer: A systematic review of recent advances and challenges.
    Das V; Kalita J; Pal M
    Biomed Pharmacother; 2017 Mar; 87():8-19. PubMed ID: 28040600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and epigenetic markers in colorectal cancer screening: recent advances.
    Singh MP; Rai S; Suyal S; Singh SK; Singh NK; Agarwal A; Srivastava S
    Expert Rev Mol Diagn; 2017 Jul; 17(7):665-685. PubMed ID: 28562109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer.
    Coppedè F; Lopomo A; Spisni R; Migliore L
    World J Gastroenterol; 2014 Jan; 20(4):943-56. PubMed ID: 24574767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and molecular origins of colorectal Cancer among the Iranians: an update.
    Abbaszadegan MR; Moghbeli M
    Diagn Pathol; 2018 Dec; 13(1):97. PubMed ID: 30579343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspectives on new biomarkers in gastric cancer: diagnostic and prognostic applications.
    Pinheiro Ddo R; Ferreira WA; Barros MB; Araújo MD; Rodrigues-Antunes S; Borges Bdo N
    World J Gastroenterol; 2014 Sep; 20(33):11574-85. PubMed ID: 25206265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteogenomic biomarkers in colorectal cancers: clinical applications.
    Binetti M; Lauro A; Vaccari S; Cervellera M; Tonini V
    Expert Rev Proteomics; 2020 May; 17(5):355-363. PubMed ID: 32536221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic biomarkers in colorectal cancer: premises and prospects.
    Zamani M; Hosseini SV; Mokarram P
    Biomarkers; 2018 Mar; 23(2):105-114. PubMed ID: 27788596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic Biomarkers in Colorectal Cancer.
    Verma M; Kumar V
    Mol Diagn Ther; 2017 Apr; 21(2):153-165. PubMed ID: 27878475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and epigenetic marker-based DNA test of stool is a promising approach for colorectal cancer screening.
    An SW; Kim NK; Chung HC
    Yonsei Med J; 2009 Jun; 50(3):331-4. PubMed ID: 19568592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in epigenetic biomarker research in colorectal cancer.
    Wang X; Kuang YY; Hu XT
    World J Gastroenterol; 2014 Apr; 20(15):4276-87. PubMed ID: 24764665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic DNA methylation markers for sporadic colorectal cancer: a systematic review.
    Draht MXG; Goudkade D; Koch A; Grabsch HI; Weijenberg MP; van Engeland M; Melotte V; Smits KM
    Clin Epigenetics; 2018; 10():35. PubMed ID: 29564023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevance of MicroRNAs as Potential Diagnostic and Prognostic Markers in Colorectal Cancer.
    Hibner G; Kimsa-Furdzik M; Francuz T
    Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30262723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRC-113 gene expression signature for predicting prognosis in patients with colorectal cancer.
    Nguyen MN; Choi TG; Nguyen DT; Kim JH; Jo YH; Shahid M; Akter S; Aryal SN; Yoo JY; Ahn YJ; Cho KM; Lee JS; Choe W; Kang I; Ha J; Kim SS
    Oncotarget; 2015 Oct; 6(31):31674-92. PubMed ID: 26397224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assimilating Epigenetics and Transcriptomics for the Identification of Prognostic Novel Biomarkers and Imminent Targets in Colorectal Carcinoma with Therapeutic Potential.
    Ray SK; Mukherjee S
    Curr Mol Med; 2023; 23(8):784-798. PubMed ID: 35546765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New trends in molecular and cellular biomarker discovery for colorectal cancer.
    Aghagolzadeh P; Radpour R
    World J Gastroenterol; 2016 Jul; 22(25):5678-93. PubMed ID: 27433083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic Molecular Subtypes in Optimizing Personalized Therapy for Metastatic Colorectal Cancer.
    Włodarczyk M; Włodarczyk J; Siwiński P; Sobolewska-Włodarczyk A; Fichna J
    Curr Drug Targets; 2018; 19(15):1731-1737. PubMed ID: 30073926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic Biomarkers in Colorectal Cancer Patients Receiving Adjuvant or Neoadjuvant Therapy: A Systematic Review of Epidemiological Studies.
    Barchitta M; Maugeri A; Li Destri G; Basile G; Agodi A
    Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31390840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic Alteration in Colorectal Cancer: Potential Diagnostic and Prognostic Implications.
    Cao Q; Tian Y; Deng Z; Yang F; Chen E
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translating colorectal cancer genetics into clinically useful biomarkers.
    Morley-Bunker A; Walker LC; Currie MJ; Pearson J; Eglinton T
    Colorectal Dis; 2016 Aug; 18(8):749-62. PubMed ID: 26990814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.